Evidence map›Paper›PMID 42145699›Full record

ArticleBiomedical optics express2026

Fluorescence spectroscopy precorrection model robust to large variability of optical properties: application to point of care quantitative liver graft viability assessment.

Antoine Uzel, Arthur Gautheron, Olivier Lopez, Guillaume Rossignol, Xavier Muller, Natacha Boulanger, Michaël Sdika, Bruno Montcel

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Antoine UzelINSA-Lyon, Universite Claude Bernard Lyon 1, CNRS, Inserm, CREATIS UMR5220, U1294, F-69100, Lyon, France.ORCID https://orcid.org/0009-0006-7329-2878
Arthur GautheronINSA-Lyon, Universite Claude Bernard Lyon 1, CNRS, Inserm, CREATIS UMR5220, U1294, F-69100, Lyon, France.ORCID https://orcid.org/0000-0002-9847-5367
Olivier LopezAix Marseille Université, LIIE, Marseille, France.
Guillaume RossignolDepartment of Pediatric Surgery, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, University of Lyon I, 69500 Lyon, France.
Xavier MullerDepartment of Surgery and Liver Transplantation, Croix-Rousse University Hospital, University of Lyon I, Lyon, France.
Natacha BoulangerDepartment of Surgery and Liver Transplantation, Croix-Rousse University Hospital, University of Lyon I, Lyon, France.
Michaël SdikaINSA-Lyon, Universite Claude Bernard Lyon 1, CNRS, Inserm, CREATIS UMR5220, U1294, F-69100, Lyon, France.
Bruno MontcelINSA-Lyon, Universite Claude Bernard Lyon 1, CNRS, Inserm, CREATIS UMR5220, U1294, F-69100, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical properties correction models for fluorescence spectroscopy faced limitations due to the high variability of optical properties. Typically, the point-of-care assessment of liver graft viability remains a critical challenge in transplantation medicine, where current methods rely on subjective visual inspection and delayed laboratory biomarkers. While optical approaches offer promising solutions to this challenge, the unique characteristics of liver grafts, which undergo highly varying conditions from procurement to transplantation, ranging from blood perfusion to ischemic phases and perfusion with transparent solutions, create an extremely wide dynamic range of optical properties that challenge state-of-the-art optical models. We present a novel method combining fluorescence spectroscopy and diffuse reflectance measurements, accounting for the large variability in optical properties and adapted for liver graft viability assessment. Our approach corrects for tissue optical properties using a dual-modality system that measures both fluorescence and diffuse reflectance spectra, enabling accurate quantification of metabolic fluorophores such as NADH and FAD. The method was validated on tissue-mimicking phantoms with varying optical properties and demonstrated superior performance compared to state-of-the-art correction techniques, with quantification accuracy improved by at least a factor of 1.5 and a capacity to detect more than 92% of the fluorophores present in the different phantoms. Clinical validation was performed on porcine ischemia-reperfusion models, showing promising results for real-time tissue viability monitoring during organ preservation and transplantation procedures.

Identifiers

PMID42145699
PMCPMC13178595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.